Bionik Laboratories Corp. recently celebrated the shipment of its 250th interactive robotic therapy system, according to a company press release.
“We are excited to reach this milestone as a company and to bring our robotic systems into medical facilities to provide innovative rehabilitation solutions for patients across the country,” Michal Prywata, cofounder, chief technology officer and director of Bionik Laboratories, said in the release. “Neurological disorders afflict millions of people each year, but current physical therapy methods are simply too limited to help patients regain the mobility they have lost. We believe our robotic systems offer the best in patient care and our continued penetration into the market showcases that.”
According to the release, Bionik solutions provide care to patients with neurological disorders in more than 200 hospitals in 20 countries. It has three globally marketed products cleared by the FDA, with four others in various stages of development. The interactive robotic therapy systems sense a patient’s movement and respond to the patient’s continually changing abilities in real time, the release noted.
“Medical treatment options are changing as technology continues to evolve,” Prywata said. “Bionik is at the forefront of a shift in the way neurological disorders are managed, utilizing robotics, artificial intelligence and real-time data and analytics to provide a significantly enhanced form of patient care. With our InMotion systems and additional products in development, we feel that the company is uniquely positioned to revolutionize the industry and become the standard of rehabilitation care.”
Disclosure: Prywata reports no relevant financial disclosures.